Cancer Letters
Volume 295, Issue 1 , Pages 38-43 , 1 September 2010

Concurrent blockade of the NF-κB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity

  • Hai-Ning He

      Affiliations

    • Laboratory of Molecular and Translational Medicine, West China Second University Hospital, Sichuan University, 20 Renminnanlu, Chengdu 610041, China
    • Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, 20 Renminnanlu Road, Chengdu 610041, China
    • ,
  • Xia Wang

      Affiliations

    • Laboratory of Molecular and Translational Medicine, West China Second University Hospital, Sichuan University, 20 Renminnanlu, Chengdu 610041, China
    • Corresponding Author InformationCorresponding authors. Tel.: +86 28 85503773; fax: +86 28 85503604 (X. Wang).
    • ,
  • Xue-Lian Zheng

      Affiliations

    • Laboratory of Molecular and Translational Medicine, West China Second University Hospital, Sichuan University, 20 Renminnanlu, Chengdu 610041, China
    • ,
  • Hong Sun

      Affiliations

    • Department of Forensic Biology, West China School of Preclinical and Forensic Medicine, Sichuan University, 17 Renminnanlu Road, Chengdu 610041, China
    • ,
  • Xun-Wei Shi

      Affiliations

    • Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, 20 Renminnanlu Road, Chengdu 610041, China
    • ,
  • Ying-Jia Zhong

      Affiliations

    • Department of Forensic Analytical Toxicology, West China School of Preclinical and Forensic Medicine, Sichuan University, 17 Renminnanlu Road, Chengdu 610041, China
    • ,
  • Bo Huang

      Affiliations

    • Laboratory of Molecular and Translational Medicine, West China Second University Hospital, Sichuan University, 20 Renminnanlu, Chengdu 610041, China
    • ,
  • Lan Yang

      Affiliations

    • Department of Forensic Biology, West China School of Preclinical and Forensic Medicine, Sichuan University, 17 Renminnanlu Road, Chengdu 610041, China
    • ,
  • Jin-Ke Li

      Affiliations

    • Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, 20 Renminnanlu Road, Chengdu 610041, China
    • ,
  • Lin-Chuan Liao

      Affiliations

    • Department of Forensic Analytical Toxicology, West China School of Preclinical and Forensic Medicine, Sichuan University, 17 Renminnanlu Road, Chengdu 610041, China
    • ,
  • Lin Zhang

      Affiliations

    • Laboratory of Molecular and Translational Medicine, West China Second University Hospital, Sichuan University, 20 Renminnanlu, Chengdu 610041, China
    • ,
  • Li-Na Hu

      Affiliations

    • Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, 20 Renminnanlu Road, Chengdu 610041, China
    • Corresponding Author InformationCorresponding authors. Tel.: +86 28 85503773; fax: +86 28 85503604 (X. Wang).
    • ,
  • Yong Lin

      Affiliations

    • Laboratory of Molecular and Translational Medicine, West China Second University Hospital, Sichuan University, 20 Renminnanlu, Chengdu 610041, China
    • Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, 20 Renminnanlu Road, Chengdu 610041, China

Received 2 December 2009 ,Revised 8 February 2010 ,Accepted 11 February 2010.

References 

  1. Huang Y, Anderle P, Bussey KJ, Barbacioru C, Shankavaram U, Dai Z, et al. Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res. 2004;64:4294–4301
  2. Guillermet-Guibert J, Davenne L, Pchejetski D, Saint-Laurent N, Brizuela L, Guilbeau-Frugier C, et al. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug. Mol. Cancer Ther. 2009;8:809–820
  3. Biliran H, Wang Y, Banerjee S, Xu H, Heng H, Thakur A, et al. Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line. Clin. Cancer Res. 2005;11:6075–6086
  4. Banerjee S, Wang Z, Kong D, Sarkar FH. 3,3′-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer. Cancer Res. 2009;69:5592–5600
  5. Wang X, Chen W, Zeng W, Bai L, Tesfaigzi Y, Belinsky SA, et al. Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells. Mol. Cancer Ther. 2008;7:1156–1163
  6. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18:2195–2224
  7. Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell. 2004;6:203–208
  8. Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM, Zhou BP. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell. 2009;15:416–428
  9. Lee H, Herrmann A, Deng JH, Kujawski M, Niu G, Li Z, et al. Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell. 2009;15:283–293
  10. Lin Y, Bai L, Chen W, Xu S. The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets. 2010;14:45–55
  11. Chen W, Wang X, Bai L, Liang X, Zhuang J, Lin Y. Blockage of NF-kappaB by IKKbeta- or RelA-siRNA rather than the NF-kappaB super-suppressor IkappaBalpha mutant potentiates adriamycin-induced cytotoxicity in lung cancer cells. J. Cell. Biochem. 2008;105:554–561
  12. Fine B, Hodakoski C, Koujak S, Su T, Saal LH, Maurer M, et al. Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a. Science. 2009;325:1261–1265
  13. Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, Lingle W, et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell. 2009;16:259–266
  14. Caporali S, Levati L, Starace G, Ragone G, Bonmassar E, Alvino E, et al. AKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition. Mol. Pharmacol. 2008;74:173–183
  15. Belyanskaya LL, Hopkins-Donaldson S, Kurtz S, Simoes-Wust AP, Yousefi S, Simon HU, et al. Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation. Int. J. Cancer. 2005;117:755–763
  16. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer. 2002;2:489–501
  17. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 1999;401:82–85
  18. Wang X, Chen W, Lin Y. Sensitization of TNF-induced cytotoxicity in lung cancer cells by concurrent suppression of the NF-kappaB and Akt pathways. Biochem. Biophys. Res. Commun. 2007;355:807–812
  19. Rahman KM, Ali S, Aboukameel A, Sarkar SH, Wang Z, Philip PA, et al. Inactivation of NF-kappaB by 3,3′-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells. Mol. Cancer Ther. 2007;6:2757–2765
  20. Wang X, Ju W, Renouard J, Aden J, Belinsky SA, Lin Y. 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway. Cancer Res. 2006;66:1089–1095
  21. Bai L, Chen W, Chen W, Wang X, Tang H, Lin Y. IKKbeta-mediated nuclear factor-kappaB activation attenuates SMAC mimetic-induced apoptosis in cancer cells. Mol. Cancer Ther. 2009;8:1636–1645
  22. Hur GM, Lewis J, Yang Q, Lin Y, Nakano H, Nedospasov S, et al. The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. Genes Dev. 2003;17:873–882
  23. Hoekstra AV, Ward EC, Hardt JL, Lurain JR, Singh DK, Buttin BM, et al. Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1. Gynecol. Oncol. 2008;108:609–618
  24. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004;431:461–466
  25. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell. 2004;6:297–305
  26. Baud V, Karin M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat. Rev. Drug Discov. 2009;8:33–40
  27. Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB, et al. NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc. Natl. Acad. Sci. USA. 2004;101:10137–10142
  28. Sato K, Taniguchi T, Suzuki M, Shinohara F, Takada H, Rikiishi H. Dual role of NF-kappaB in apoptosis of THP-1 cells during treatment with etoposide and lipopolysaccharide. Leukemia Res. 2004;28:63–69
  29. O.P. Veiby, M.A. Read, Chemoresistance: impact of nuclear factor (NF)-kappaB inhibition by small interfering RNA. Commentary re J. Guo et al., Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the NF-kappaB p65 subunit. Clin Cancer Res 2004;10:3333–3341, Clin Cancer Res 10 (2004) 3262–3264.
  30. Singh NP, Nagarkatti M, Nagarkatti PS. Role of dioxin response element and nuclear factor-kappaB motifs in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated regulation of Fas and Fas ligand expression. Mol. Pharmacol. 2007;71:145–157
  31. Kim SB, Kim JS, Lee JH, Yoon WJ, Lee DS, Ko MS, et al. NF-kappaB activation is required for cisplatin-induced apoptosis in head and neck squamous carcinoma cells. FEBS Lett. 2006;580:311–318
  32. Janssens S, Tschopp J. Signals from with the DNA-damage-induced NF-kappaB response. Cell Death Differ. 2006;13:773–784
  33. Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, Sarkar FH. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res. 2005;65:6934–6942
  34. Yu HG, Ai YW, Yu LL, Zhou XD, Liu J, Li JH, et al. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int. J. Cancer. 2008;122:433–443

PII: S0304-3835(10)00099-6

doi: 10.1016/j.canlet.2010.02.011

Cancer Letters
Volume 295, Issue 1 , Pages 38-43 , 1 September 2010

Article Tools

* Image Usage & Resolution